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Abstract. The article presents the data concerning 
various chains of the blood coagulative system, anticoagu-
lative blood activity, fibrinolysis and systemic plasma pro-
teolysis in correlation with hemorheological parameters 
with comorbid chronic acalculouscholecystitis (CAC) and 
somatoform vegetative dysfunction (SVD) or essential 
hypertension (EH). The objective of the work is to deter-
mine reliable mechanisms of progressing these diseases and 
elaborate the ways to correct disorders found.  
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Introduction. Essential hypertension (EH) re-
mains the main health problem in the majority of the 
world countries due to its influence upon mortality 
and morbidity rates, considerably decreasing ability 
of the population to work[2, 5,]. Occurrence of EH 
increases with age and constitutes about 44 % in 
individuals of 40-60 years, and practically 60 % 
among those older than 70 [1]. At the same time, the 
number of young people with EH has increased sub-
stantially lately [4]. Considering the afore-
mentioned, the problem of learning and supplement-
ing pathogenesis of EH against accompanying pa-
thology, detecting new, previously unknown links 
and mechanisms of its progressing remains always 
topical.  
Premorbid period of EH is more frequently real-
ized through somatoform vegetative dysfunction 
(SVD) being one of the links of the “cardio-vascular 
continuum” [2, 3], stipulating the necessity to study 
the conditions of its occurrence, causes of formation 
and progression.  
The diagnosis of SVD assumes vegetative dys-
function of the gastrointestinal tract (GIT), develop-
ment of various types of gallbladder dysfunction 
(GD) and bile ducts dysfunction (BDD) in particular, 
which are widely spread functional diseases of the 
biliary tract and found among the population with the 
frequency from 5 to 20 %, at the same time being 
predictors of the development of chronic acalculous 
cholecystitis (CAC) and cholecystolithiasis (CCL) 
[7, 8, 9]. 
Objective. to study the peculiarities of links of the 
blood coagulative system, anticoagulative blood activity, 
fibrinolysis and systemic plasma proteolysis with comor-
bid course of CAC and SVD or EH, and to find possible 
mechanisms of progressing these diseases.  
Materials and methods. To realize these tasks 138 
patients with CAC and comorbid SVD were examined. 
Depending on the variant of SVD all the patients with 
CAC were divided into three groups: the 1st group – 31 
patients with CAC and SVD by hypertensive type 
(hyperTT); the 2nd group – 35 patients with CAC and SVD 
by hypotensive type (hypoTT) and the 3rd one – 22 patients 
with CAC and cardiac neurosis (CN). The 4th group in-
cluded 40 individuals with II stage EH. The control group 
contained 30 practically healthy individuals of a corre-
sponding age.  
 Blood for biochemical tests was taken from the 
ulnar vein in the morning on empty stomach. To 
study the regulation system of blood aggregative 
condition it was collected into silicon tubes using 
3,8 % sodium citrate solution as a stabilizer in the 
ration of 1:9. General coagulative blood potential 
was determined by prothrombin time index (PTI), 
fibrinolytic plasma activity (FPA), potential plasmi-
nogen activity, fibrinogen content in the blood 
plasma, antithrombin III activity, factor XIII activity 
were detected by means of the sets of reagents of the 
„DanushLtd” (Lviv) according to N.Tits methods. 
With the use of reagents of this firm the condition of 
enzymatic and non-enzymatic fibrinolysis, prote-
olytic activity of blood plasma was studied using 
nitroalbumin (intensity of nitroalbumin lysis), nitro-
casein (intensity of nitrocasein lysis), nitrocol 
(intensity of nitrocol lysis). The material was proc-
essed statistically by means of parametric and non-
parametric methods of variational statistics.  
Results. The analysis of the examination of the co-
agulative hemostasis 2nd phase showed that PTI of the 
second group patients (Table 1) was 21,9 % lower than 
that of practically healthy individuals (р<0,05). At the 
same time, PTI in patients of the 1st, 3rd and 4th 
groups was characterized by the tendency to increas-
ing which was indicative of the risk of hypercoagula-
tive syndrome formation (р>0,05). Examination of 
the 3rd phase of coagulative hemostasis by the con-
tent of fibrinogen in the blood is indicative of the 
fact that this index was reliably low in all the groups: 
patients of the 1st group – on 34,4%, 2nd group – on 
48,8 %, 3rd – on 26,6 % (р1-3<0,05), except the 4th 
group where it increased on 31,3 % (р<0,05) and 
reliably differed in comparison between groups 
(р<0,05). Increased content of fibrinogen in patients 
with CAC and EH is indicative of the formation of 
hypercoagulative syndrome. Decreased fibrinogen 
content in the blood of patients with CAC and SVD 
Буковинський медичний вісник        Том 18, № 4 (72), 2014 
162 
 
is indicative either of insufficient synthesis of I sedi-
mentation blood factor in the liver (although, the liver 
functional state in the patients examined was within 
the norm), or activation of the hemostasis system in 
response to inflammation promoting the development 
of condition of hypercoagulation, formation of minute 
clots on the walls, and involvement of a considerable 
amount of fibrinogen in the process.  
Analysis of the blood anticoagulative potential found 
decreased activity of AT-III in the 1st, 3rd and 4th groups 
with maximal reduction in the 3rd and 4th groups – on 
21,3 % and 29,7 % respectively (р<0,05) as compared 
with the group of practically healthy people. But 
reduced activity of AT-III in the 1st group was not 
reliable (p>0,05), and in the 2nd group this index was 
the tendency to increasing (p>0,05). АТ-III is a com-
ponent of the anticoagulative system and the factor 
inhibiting proteolysis and fibrinolysis. Total enzy-
matic activity (TEA) of the blood plasma in patients 
from the 1st and 3rd groups was reliably lower than 
those control indices: in the 1st group – on 13,5 %, in 
the 3rd group – on 31,8 % (р<0,05). In the second 
group of patients TEA of the blood plasma was not 
considerable – on 11,2 % (р<0,05), which is indica-
tive of the activation of the balance maintaining 
compensatory mechanisms in the hemostasis system 
of this group of patients. TEA inhibition in the 1st, 3rd 
and 4th groups of patients occurred due to enzymatic 
fibrinolytic activity (EFA) of the blood plasma de-
crease: in comparison with the control group this 
index was reliably lower in the 1st group of patients – 
on 32,5 %, in the third group – on 66,7 %, in the 4th 
one – on 48,3 %, while in the 2nd group insufficient 
reliable inhibition of EFA was found – on 16,7 % 
(р1-4<0,05). At the same time, non-enzymatic fibri-
nolytic activity (NEFA) of the blood plasma in all 
the groups of patients increased as NEFA parameters 
in all the groups were higher as compared with the 
group of practically healthy individuals in 1,4, 1,9 
and 1,6, 1,6 times respectively (р1-4<0,05). That is, 
in the second group of patients NEFA achieved a 
compensatory maximal intensity (р<0,05). At the 
same time, Hagemann-dependant fibrinolysis reli-
able decrease was found: in the 1st group – in у 1,6 
times, in the 2nd one – in 1,2 times, in the 3rd and 4th 
groups it was twice lower (р1-4<0,05) as compared 
with the group of practically healthy individuals and 
reliable difference between the 2ndr and 3rd, 2nd and 
4th groups (р<0,05). This fact is indicative of one of 
the causes of EFA inhibition in all the groups. At the 
same time, the analysis of potential plasminogen 
activity (PPA) index reflects the mechanisms of in-
creasing NEFA in the patients examined: thus, PPA 
in patients of the 1st group changed unreliably, but in 
the patients of the 2nd and 3rd groups PPA increased 
reliably on 19,7 % and 16,9 % respectively (р<0,05) 
(Table 1).  
Fibrin-stabilizing factor activity in the 1st and 
2nd groups of patients changes unreliably, and in the 
3rd and 4th groups – decreased on 24,8 % and 33,7 % 
respectively (р<0,05) (Table 1), which is indicative 
of disorders of blood sedimentation post-coagulative 
phase. Results of examination of factors of coagula-
tive hemostasis, anticoagulative and fibrinolytic sys-
tems in patients with CAC with SVD against Hy-
perTT and CN, and comorbidity between CAC and 
EH is indicative of the tendency to the formation of 
hypercoagulative syndrome due to insufficiency of 
factors of the anticoagulative system and fibrinolytic 
system.  
Analysis of examination of the processes of 
plasma proteolysis and collagenolysis are indicative 
of the fact that increased intensity of low molecular 
proteins lysis was found in all the patients with CAC 
(р<0,05) (Table2), at the same time, in the 1st group 
of patients ILAA was in 1,5 times higher than in 
practically healthy people, in the 2nd group – in 1,7 
times, in the 3rd group – in 1,4 times, in the 4th one – 
in 1,5 times (р1-4<0,05) with reliable difference be-
tween all the groups, except the 1st and 3rd ones 
(p>0,05). Maximal activation indices of the systemic 
proteolysis were registered in patients with CAC 
accompanied by SVD by HypoTT (Table 2), mini-
mal ones were found in patients with CAC with CN. 
At the same time, patients with CAC accompanied 
by SVD demonstrated more considerable increase of 
intensity of high molecular proteins unlimited prote-
olysis as compared with practically healthy people – 
in 1.8, 2.2, 1.6 and 1.8 times respectively in the 
groups 1, 2, 3, 4 (р1-4<0,05) with reliable difference 
between the 2nd group and the groups 1 and 3 
(р<0,05) (Table2). Changes of intensity of azocol 
lysis were also registered: in patients of the 1st and 
4th groups the index increased unreliably as com-
pared with practically healthy people, in the 3rd 
group – 16,7% increase was found, and in the 2nd 
group a maximal intensity of collagenosis was found 
– increase on 53,6 % as compared with practically 
healthy individuals (PHI) (р2,3<0,05). Thus, intensity 
of collagen proteolytic degradation in the blood of 
patients with HypoTT was found to be in 1,5 times 
higher (р<0,05) than in patients with HyperTT SVD.  
Conclusion 
Results of examination of the factors of blood 
coagulative system, anticoagulative blood activity, fibri-
nolysis and systemic plasma proteolysis with comorbid 
course of CAC and SVD with HyperTT and CN as well as 
with comorbid EH are indicative of a tendency to the for-
mation of hypercoagulative syndrome due to insufficient 
factors of anticoagulative and fibrinolytic systems. In pa-
tients with CAC and SVD with HypoTT a deficiency of 
fibrinogen circulating pool was found due to activation of 
the fibrinolysis. Peculiarities of proteolytic blood ac-
tivity disorders in patients with CAC with comorbid 
SVD of all the forms and EH are increased intensity 
of lysis of low and high molecular proteins and col-
lagenolytic blood activity, maximally revealed in 
patients with HypoTT SVD.  
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ВЛИЯНИЕ ФАКТОРОВ ГЕМОСТАЗА, ФИБРИНОЛИЗА И ПРОТЕОЛИТИЧЕСКОЙ  
СИСТЕМЫ НА ВОЗНИКНОВЕНИЕ И ПРОГРЕССИРОВАНИЕ СОМАТОФОРМНОЙ  
ВЕГЕТАТИВНОЙ ДИСФУНКЦИИ И ЭССЕНЦИАЛЬНОЙ ГИПЕРТЕНЗИИ  
У ПАЦИЕНТОВ С ХРОНИЧЕСКИМ НЕКАЛЬКУЛЬОЗНЫМ ХОЛЕЦИСТИТОМ 
О.С. Хухлина, А.А. Антонив, Ю.И. Войткевич 
Резюме. В статье наведены данные об анализе различных звеньев системы свертывания крови, противосверты-
вающей активности крови, фибринолиза и системного плазменного протеолиза в соотношении с гемореологичес-
кими параметрами при совместном течении хронического некалькулезного холецистита (ХБХ) и соматоформной 
вегетативной дисфункции (СВД) или гипертонической болезни (ГБ). Цель работы – установить вероятные механиз-
мы прогрессирования этих заболеваний и в дальнейшем разработать пути коррекции выявленных нарушений. 
Ключевые слова: хронический некалькульозный холецистит, соматоформная вегетативная дисфункция, ессен-
циальная гипертензия, фибринолиз, протеолиз. 
ВПЛИВ ФАКТОРІВ ГЕМОСТАЗУ, ФІБРИНОЛІЗУ ТА ПРОТЕОЛІТИЧНОЇ СИСТЕМИ  
У ВИНИКНЕННІ ТА ПРОГРЕСУВАННІ ВЕГЕТАТИВНОЇ СОМАТОФОРМНОЇ  
ВЕГЕТАТИВНОЇ ДИСФУНКЦІЇ ТА ЕСЕНЦІЙНОЇ ГІПЕРТЕНЗІЇ У ПАЦІЄНТІВ  
ІЗ ХРОНІЧНИМ НЕКАЛЬКУЛЬОЗНИМ ХОЛЕЦИСТИТОМ 
О.С. Хухліна, А.А. Антонів, Ю.І. Войткевич 
Резюме. У статті наведенні дані про аналіз різних ланок системи згортання крові, протизгортальної активності 
крові, фібринолізу та системного плазмового протеолізу в співвідношенні з гемореологічними параметрами при 
поєднаному перебігу хронічного некалькульозного холециститу (ХНХ) та соматоформної вегетативної дисфункції 
(СВД) або гіпертонічної хвороби (ГХ). Мета роботи – встановити ймовірні механізми прогресування цих захворю-
вань і в подальшому розробити шляхи корекції виявлених порушень. 
Ключові слова: хронічний некалькульозний холецистит, соматоформна вегетативна дисфункція, есенційна 
гіпертензія, фібриноліз, протеоліз. 
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